The Latest Breaking News from MPP

Trump-era Remain in Mexico program under new scrutiny ahead of Supreme Court ruling

A migrant woman tried to take her own life earlier this month while waiting in a shelter in Mexico, Axios has learned.

Axios · Jun 22, 2022

Exclusive-Three migrants were kidnapped in Mexico. The U.S. had vowed to protect them

Three asylum seekers were kidnapped in April while in a U.S. migration program that had placed them in the care of Mexican officials in the city of Nuevo Laredo, across the border from Texas, one of the victims and the U.N. migration agency said.

Reuters · Jun 21, 2022

Meet The Groups Leading Cannabis Legalization, Nominated For The Industry's Top Award

After a blowout event in Miami during the week of 4/20, the Benzinga Cannabis Capital Conference (CCC) is gearing up for a repeat performance in Chicago on Sept. 13-14.

Benzinga · Jun 10, 2022

Hyderabad cos get licence for Pfizer’s Covid pill

HYDERABAD: Apart from Hyderabad-based pharma major Aurobindo Pharma Limited, other city-based pharma players like Granules India Ltd, MSN Group and SMS Pharmaceuticals too have received licences from the UN-backed Medicines Patent Pool (MPP) to manufacture and supply a generic version of nirmatrelvir, a key component of Pfizer’s oral Covid-19 drug…

The Times of India · Mar 18, 2022

Aurobindo gets licence for supply of Pfizer’s Covid pill

HYDERABAD: Pharma major Aurobindo Pharma Limited has inked a sub-license agreement with the United Nations-backed public health organisation Medicines Patent Pool (MPP) for manufacturing and supplying a generic version of Pfizer’s oral Covid-19 treatment drug nirmatrelvir to 95 countries, including India.

The Times of India · Mar 17, 2022

19 firms in India to make Pfizer’s oral COVID-19 antiviral drug

They have signed sublicence agreements with United Nations-backed Medicines Patent Pool

The Hindu · Mar 17, 2022

Pfizer Commits 10M Courses Of COVID-19 Oral Antiviral To Developing Countries: Reuters

Pfizer Inc (NYSE:PFE) is expected to provide around 10 million courses of its highly effective COVID-19 antiviral treatment Paxlovid to low- and middle-income countries in 2022, reports Reuters citing an official with the Global Fund. The Fund's head of strategy for policy, Harley Feldbaum, said Pfizer had committed at least that many…

Benzinga · Mar 3, 2022

Dad's death sent woman down dark path of drug and alcohol addiction

Kerry Wells said everything she had ever known 'became tipped on its head'

Liverpool Echo · Feb 26, 2022

Some asylum aspirants pin hopes on Trump-era policy

When the Biden administration extended a Trump-era policy to make asylum-seekers wait in Mexico for hearings in Brownsville, Texas, it was barely noticed _ the latest step in a slow-moving rollout to make asylum hearings available

The Independent UK · Jan 30, 2022

Dozens of firms to make cheap version of Merck COVID pill for poorer nations

Nearly 30 generic drugmakers in Asia, Africa and the Middle East will make cheap versions of Merck Co's COVID-19 pill, under a landmark U.N.-backed deal to give poorer nations wider access to a drug seen as a weapon in fighting the pandemic.

Reuters · Jan 20, 2022